<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Genet Res (Camb)</journal-id>
<journal-id journal-id-type="iso-abbrev">Genet Res (Camb)</journal-id>
<journal-id journal-id-type="publisher-id">GRH</journal-id>
<journal-title-group>
<journal-title>Genetics Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-6723</issn>
<issn pub-type="epub">1469-5073</issn>
<publisher>
<publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>Cambridge, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26521961</article-id>
<article-id pub-id-type="pmc">6863625</article-id>
<article-id pub-id-type="doi">10.1017/S0016672315000178</article-id>
<article-id pub-id-type="pii">S0016672315000178</article-id>
<article-id pub-id-type="publisher-id">00017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Perspective</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Challenges of using next generation sequencing in newborn screening</article-title>
<alt-title alt-title-type="left-running">E. Reinstein</alt-title>
<alt-title alt-title-type="right-running">Challenges of using next generation sequencing in newborn screening</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>REINSTEIN</surname>
<given-names>EYAL</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>The Raphael Recanati Genetic Institute</institution>, <addr-line>Rabin Medical Center</addr-line>, <addr-line>Petach-Tikva</addr-line>, <country>Israel</country></aff>
<aff id="aff2"><label>2</label><addr-line>Sackler School of Medicine</addr-line>, <institution>Tel Aviv University</institution>, <country>Israel</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label><addr-line>Corresponding author:</addr-line><institution>The Raphael Recanati Genetics Institute</institution>, <addr-line>Rabin Medical Center</addr-line>, <addr-line>Petach-Tikva</addr-line>, <country>Israel</country>. Fax: <fax>+972-3-937-7660</fax>. E-mail: <email>reinstein.eyal@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>11</month>
<year>2015</year>
</pub-date>
<volume>97</volume>
<elocation-id>e21</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>5</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>7</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Â© Cambridge University Press 2015</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Cambridge University Press</copyright-holder>
</permissions>
<self-uri xlink:href="S0016672315000178a.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="normal">
<title>Summary</title>
<p>Whole-genome and whole-exome sequencing for clinical applications is now an integral part of medical genetics practice. The term newborn screening refers to public health programs designed to screen newborns for various treatable metabolic conditions, by measuring levels of circulating blood metabolites. The availability and significant decrease in sequencing costs has raised the question of whether metabolic newborn screening should be replaced by whole-genome or whole-exome sequencing. While newborn genome sequencing can potentially increase the number of disorders identified by newborn screening, the generalization of its practice raises a number of important ethical issues. This short article argues that there are medical, psychological, ethical and economic reasons why widespread dissemination of newborn screening is still premature.</p>
</abstract>
<counts>
<ref-count count="29"></ref-count>
<page-count count="4"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>